story of the week
Gene Therapy With Etranacogene Dezaparvovec for Hemophilia B
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
N. Engl. J. Med 2023 Feb 23;388(8)706-718, SW Pipe, FWG Leebeek, M Recht, NS Key, G Castaman, W Miesbach, S Lattimore, K Peerlinck, P Van der Valk, M Coppens, P Kampmann, K Meijer, N O'Connell, KJ Pasi, DP Hart, R Kazmi, J Astermark, CRJR Hermans, R Klamroth, R Lemons, N Visweshwar, A von Drygalski, G Young, SE Crary, M Escobar, E Gomez, R Kruse-Jarres, DV Quon, E Symington, M Wang, AP Wheeler, R Gut, YP Liu, RE Dolmetsch, DL Cooper, Y Li, B Goldstein, PE MonahanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.